UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Medline ® Abstract for Reference 112

of 'Chemotherapy for advanced exocrine pancreatic cancer'

112
TI
A randomized phase 3 study comparing efficacy and safety of gemcitabine and irinotecan to gemcitabine alone in patients with locally advanced or metastatic pancreatic cancer who have not received prior systemic therapy (abstract)
AU
Rocha Lima CM, Rotche R, Jeffery M, et AL
SO
Proc Am Soc Clin Oncol. 2003;22:251a.
 
AD